Nano-in-Microparticles for Pulmonary Drug Delivery DOI
Nasser Alhajj, Niall J. O’Reilly, Helen Cathcart

et al.

Published: Jan. 1, 2023

Nanoparticles have been developed to overcome the limitation of free therapeutics and enable targeting specific sites in a controlled manner; they proven be effective as drug carriers diagnostic tools. Pulmonary delivery is greatly preferred treatment lung diseases has its advantages over other routes systemic well. However, delivering nanoparticles hindered by their physical instability poor deposition efficiency due particle-particle interaction low inertia, respectively. Developing inhalable part an solid state dry powder combines pulmonary nanoparticle systems offers unique advantages. Several particle engineering techniques utilized combine within form micron-scale carrier with improved handling aerosolization properties ability release upon lungs. This chapter will describe different classes nano-in-micro frameworks. The used for developing these frameworks also discussed.

Language: Английский

Enhanced drug delivery systems for the management of respiratory disorders DOI

C. Sarath Chandran,

Krishnameera Sajayan,

P. K. Anjana

et al.

Elsevier eBooks, Journal Year: 2024, Volume and Issue: unknown, P. 145 - 162

Published: Nov. 1, 2024

Language: Английский

Citations

0

Implementation Of Box Behnken Design To Fabricate The Formulation, Optimization And Dissolution Of Blueberry Nanosuspension DOI Open Access

Geeta Mahlawat,

Tarun Virmani, Muhammad Arif

et al.

Journal of Pharmaceutical Negative Results, Journal Year: 2022, Volume and Issue: unknown, P. 595 - 605

Published: Oct. 22, 2022

The present study aims to enhance the bioavailability of Blueberry by formulating it as nanosuspension. mainly consists ofanthocyanins which have strong antihyperlipidemic activity but suffers from low causes hindrances in itstherapeutic treat hyperlipidemia. Hence improve its bioavailability, nanosuspension blueberry was prepared. BoxBehnken design applied predict effect independent variables namely concentration chitosan and oftripolyphosphate (TPP) stirring speed on two responses particle size entrapment efficiency. suggested thata formulation having a 205.05nm efficiency 76.60 % will be an optimized if haschitosan, TPP,and 0.5%, 0.05%,and 1050 rpm respectively. prepared itwas found that 198.5 nm 75.14±0.56 In addition, wasfound polydispersity index, refractive zeta potential 0.351, 1.33, 21.08mv respectively.SEM analysis showed thedroplet under 200nm.When compared towards with drug extract release shows controlled releaseof up 8 hrs enhances suspension maximum 2hrs whichshows immediate drug. As result, our research nanotechnology might utilized effective approachincreasing this article also focuses ofanthocyanin.

Language: Английский

Citations

1

Welcome to volume 18 of Nanomedicine DOI

Dan Kytka-Sharpe

Nanomedicine, Journal Year: 2023, Volume and Issue: 18(1), P. 1 - 4

Published: Jan. 1, 2023

Citations

0

Nano-in-Microparticles for Pulmonary Drug Delivery DOI
Nasser Alhajj, Niall J. O’Reilly, Helen Cathcart

et al.

Published: Jan. 1, 2023

Nanoparticles have been developed to overcome the limitation of free therapeutics and enable targeting specific sites in a controlled manner; they proven be effective as drug carriers diagnostic tools. Pulmonary delivery is greatly preferred treatment lung diseases has its advantages over other routes systemic well. However, delivering nanoparticles hindered by their physical instability poor deposition efficiency due particle-particle interaction low inertia, respectively. Developing inhalable part an solid state dry powder combines pulmonary nanoparticle systems offers unique advantages. Several particle engineering techniques utilized combine within form micron-scale carrier with improved handling aerosolization properties ability release upon lungs. This chapter will describe different classes nano-in-micro frameworks. The used for developing these frameworks also discussed.

Language: Английский

Citations

0